Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-28T11:48:43.451Z Has data issue: false hasContentIssue false
  • English
  • Français

Neuroleptic malignant syndrome

Published online by Cambridge University Press:  02 January 2018

Peter Simmons  and
Esther-Lee Marcus
Peter Simmons
Affiliation:
Department of Geriatrics, Sarah Herzog Memorial Hospital, POB 35300, Jerusalem 91351, Israel
Esther-Lee Marcus
Affiliation:
Department of Geriatrics, Sarah Herzog Memorial Hospital, POB 35300, Jerusalem 91351, Israel
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Information
The British Journal of Psychiatry , Volume 161 , Issue 5 , November 1992 , pp. 722 - 723
Copyright
Copyright © 1992 The Royal College of Psychiatrists 

References

Cohen, O., Leibovici, L., Mor, F., et al (1991) Significance of elevated levels of serum creatine phosphokinase in febrile diseases: a prospective study. Reviews of Infectious Diseases, 13, 237–242.Google Scholar
Marcus, E. L., Rudensky, B. & Sonnenblick, M. (1992) Occult elevation of CPK as a manifestation of rhabdomyolysis in the elderly. Journal of the American Geriatrics Society, 40, 454–456.Google Scholar
Pope, H. G. Jr, Keck, P. E. Jr & McElroy, S. L. (1986) Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. American Journal of Psychiatry, 143, 1227–1233.Google Scholar
Renwick, D. S., Chandraker, A. & Bannister, P. (1992) Missed neuroleptic malignant syndrome. British Medical Journal, 304, 831–832.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.